Found: 19
Select item for more details and to access through your institution.
Effects of renal impairment on the pharmacokinetics and pharmacodynamics of a novel dipeptidyl peptidase-4 inhibitor, evogliptin ( DA-1229).
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 294, doi. 10.1111/dom.12813
- By:
- Publication type:
- Article
A non-linear pharmacokinetic-pharmacodynamic relationship of metformin in healthy volunteers: An open-label, parallel group, randomized clinical study.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191258
- By:
- Publication type:
- Article
Pharmacokinetic-Pharmacodynamic Modelling of Biomarker Response to Sitagliptin in Healthy Volunteers.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2013, v. 113, n. 2, p. 113, doi. 10.1111/bcpt.12068
- By:
- Publication type:
- Article
The Effect of Therapeutic Drug Monitoring on Safety and Efficacy of Voriconazole in Invasive Fungal Infections: A Randomized Controlled Trial.
- Published in:
- Clinical Infectious Diseases, 2012, v. 55, n. 8, p. 1080, doi. 10.1093/cid/cis599
- By:
- Publication type:
- Article
Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP<sup>®</sup>) Biosimilar, to Those of NESP<sup>®</sup> After a Single Subcutaneous or Intravenous Administration to Healthy Subjects.
- Published in:
- Drug Design, Development & Therapy, 2021, v. 15, p. 1735, doi. 10.2147/DDDT.S303772
- By:
- Publication type:
- Article
Effect of food on the pharmacokinetics of YH4808, a potassium-competitive acid blocker, after single- and multiple-oral dosing in healthy subjects.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 10, p. 1261, doi. 10.1007/s00228-018-2502-9
- By:
- Publication type:
- Article
Influence of CYP2C19 Polymorphisms on the Pharmacokinetics of Omeprazole in Elderly Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 12, p. 1469, doi. 10.1002/cpdd.966
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 68, doi. 10.1002/cpdd.790
- By:
- Publication type:
- Article
A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome‐positive chronic myeloid leukemia in chronic phase: ENESTKorea.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 5, p. 1814, doi. 10.1002/cam4.1450
- By:
- Publication type:
- Article
Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-55562-4
- By:
- Publication type:
- Article
Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 8, p. 1085, doi. 10.1002/jcph.1409
- By:
- Publication type:
- Article
Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 78, n. 3, p. 556, doi. 10.1111/bcp.12368
- By:
- Publication type:
- Article
Apple juice greatly reduces systemic exposure to atenolol.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 1, p. 172, doi. 10.1111/j.1365-2125.2012.04324.x
- By:
- Publication type:
- Article
The novel carboxylesterase 1 variant c.662A>G may decrease the bioactivation of oseltamivir in humans.
- Published in:
- PLoS ONE, 2017, v. 12, n. 4, p. 1, doi. 10.1371/journal.pone.0176320
- By:
- Publication type:
- Article
Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc‐fused interleukin‐1 receptor antagonist, in healthy subjects: A first‐in‐human study.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 2, p. 372, doi. 10.1111/bcp.14161
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Tolerability of Metformin in Healthy Elderly Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 9, p. 1104, doi. 10.1002/jcph.699
- By:
- Publication type:
- Article
Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 1, p. 75, doi. 10.1177/0091270011433328
- By:
- Publication type:
- Article
Effect of CYP2C19 Polymorphism on the Pharmacokinetics of Voriconazole After Single and Multiple Doses in Healthy Volunteers.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 2, p. 195, doi. 10.1177/0091270010395510
- By:
- Publication type:
- Article
Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
- Published in:
- Epilepsia (Series 4), 2012, v. 53, n. 1, p. e9, doi. 10.1111/j.1528-1167.2011.03318.x
- By:
- Publication type:
- Article